Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Radiologe ; 60(12): 1162-1168, 2020 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-33237385

RESUMEN

OBJECTIVE: Contrast-enhanced computed tomography (CT) is a convenient method to visualize left atrial appendage (LAA) thrombi. We determined whether diagnostic accuracy improves by including dual-energy as compared to transesophageal echocardiography (TEE). Furthermore, the influence of protocol parameters on radiation dose were quantified. METHODS: Patients were assigned to the different CT protocols. All CTs were assessed qualitatively for presence of LAA thrombi and dual-energy CT scans quantitatively for iodine concentration. TEE was assessed qualitatively for the presence of thrombi. RESULTS: Of 32 enrolled patients, 6 had a thrombus in TEE. Qualitative CT assessment yielded 83% sensitivity and 88% specificity. In the 26 patients who underwent dual-energy CT, median iodine concentration was 8.6 mg/cm3 and significantly lower in patients with than without LAA thrombi ; furthermore, it provided value for detecting LAA thrombi (AUC: 0.950 vs 0.867 for combined vs. only qualitative assessment, p = 0.04). The median radiation dose was 1.83 mSv; independently lower in scanning only LAA and with prospective gating , while arrhythmia and dual-energy did not contribute independently. CONCLUSION: CT provides good diagnostic accuracy for detecting LAA thrombi, which can further be improved if iodine density measurements by dual-energy are incorporated. With an optimized protocol, reasonably low radiation dose can be achieved.


Asunto(s)
Apéndice Atrial , Ecocardiografía Transesofágica , Trombosis , Tomografía Computarizada por Rayos X , Apéndice Atrial/diagnóstico por imagen , Humanos , Estudios Prospectivos , Trombosis/diagnóstico por imagen
2.
Amino Acids ; 38(1): 167-77, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19151914

RESUMEN

The aim of this study was to determine the effects of alpha-ketoglutarate on neutrophil (PMN), free alpha-keto and amino-acid profiles as well as important reactive oxygen species (ROS) produced [superoxide anion (O(2) (-)), hydrogen peroxide (H(2)O(2))] and released myeloperoxidase (MPO) activity. Exogenous alpha-ketoglutarate significantly increased PMN alpha-ketoglutarate, pyruvate, asparagine, glutamine, asparatate, glutamate, arginine, citrulline, alanine, glycine and serine in a dose as well as duration of exposure dependent manner. Additionally, in parallel with intracellular alpha-ketoglutarate changes, increases in O(2) (-) formation, H(2)O(2)-generation and MPO activity have also been observed. We therefore believe that alpha-ketoglutarate is important for affecting PMN "susceptible free amino- and alpha-keto acid pools" although important mechanisms and backgrounds are not yet completely explored. Moreover, our results also show very clearly that changes in intragranulocytic alpha-ketoglutarate levels are relevant metabolic determinants in PMN nutrition considerably influencing and modulating the magnitude and quality of the granulocytic host defense capability as well as production of ROS.


Asunto(s)
Aminoácidos/metabolismo , Cetoácidos/metabolismo , Ácidos Cetoglutáricos/farmacología , Neutrófilos/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Adulto , Células Cultivadas , Humanos , Masculino , Neutrófilos/efectos de los fármacos , Adulto Joven
3.
Transplant Proc ; 41(6): 2616-20, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19715986

RESUMEN

p38MAP kinase plays a crucial role in intracellular signal transduction of inflammation. The inhibitor of p38 MAP kinase, FR167653, has been proven to be effective to suppress proinflammatory cytokines tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta in various animal models. The aim of our study was to investigate p38MAP kinase inhibition by FR167653 on the inflammatory profile of cells involved in vascular injury. HUVEC incubated with FR167653 in concentrations of 0.1 to 20 mumol for 24 hours were stimulated with TNF-alpha (20 ng/mL). Human monocytes were incubated with equal concentrations of FR167653 and stimulated with lipopolysaccharides (LPS; 10 microg/mL). In monocytes, p38 MAP kinase could be inhibited by FR167653 (Western blot). The cytokines IL-6 and IL-8 were dose dependently downregulated by FR167653 (enzyme-linked immunosorbent assay) [ELISA]. These results were confirmed at a transcriptional level by real-time polymerase chain reaction (PCR). Gene expression of IL-6 and IL-8 was dose dependently downregulated. The expression pattern of ICAM-1 and VCAM-1 was not altered by FR167653 (ELISA). In HUVEC, the cytokines IL-6 and IL-8 were dose dependently downregulated by FR167653 (ELISA). These results were confirmed on a transcriptional level by real-time PCR. Gene expression of IL-6 and IL-8 were also dose dependently suppressed by FR167653. In addition FR167653 downregulated the expression of the adhesion molecules ICAM-1 and VCAM-1 (ELISA). FR167653 suppressed the development of a proinflamatory profile of HUVEC and human monocytes after stimulation with TNF-alpha or LPS, respectively. These results indicated anti-inflammatory properties of FR167653 on endothelial and inflammatory cells, which may be therapeutically useful to ameliorate vascular injury.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Endotelio Vascular/fisiología , Inflamación/prevención & control , Monocitos/fisiología , Pirazoles/farmacología , Piridinas/farmacología , Venas Umbilicales/fisiología , Técnicas de Cultivo de Célula , Endotelio Vascular/citología , Endotelio Vascular/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Ensayo de Inmunoadsorción Enzimática , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Interleucina-8/genética , Cinética , Lipopolisacáridos/farmacología , Monocitos/citología , Monocitos/efectos de los fármacos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor de Necrosis Tumoral alfa/farmacología , Venas Umbilicales/citología , Venas Umbilicales/efectos de los fármacos , Proteínas Quinasas p38 Activadas por Mitógenos/antagonistas & inhibidores
4.
Transplant Proc ; 41(6): 2621-4, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19715987

RESUMEN

Accelerated rejection due to host sensitization to major histocompatibility complex antigens is a critical problem in clinical organ transplantation in patients who have previously received an organ transplant, experienced acute rejection episodes, received blood transfusions, or been pregnant. The precise pathologic mechanisms underlying accelerated rejection have not been characterized. Herein, we describe apoptosis during T- and B-cell-driven accelerated rejection of cardiac allografts in presensitized recipients. In an established accelerated rejection model, Lewis rats were sensitized to skin grafts from Wistar-Furth rats; after 7 days, they received Wistar-Furth hearts. These grafts were rejected within 24 hours posttransplantation compared with 10 days in nonsensitized recipients (acute rejection, n = 5). Apoptosis was observed during accelerated rejection of cardiac allografts but not in naïve recipients of hearts, as demonstrated at DNA laddering and TUNEL (terminal deoxynucleotide transferase-mediated deoxyuridine triphosphate nick-end labeling) assay. Apoptosis was discovered as a thus far unknown effector mechanism in accelerated cardiac transplant rejection that accompanies combined cellular and humoral immune alloreactivity. Apoptotic cell death in accelerated rejection and the cascade of upstream and downstream events leading to or resulting from this process should be considered critical steps in the pathogenesis of accelerated rejection.


Asunto(s)
Trasplante de Corazón/inmunología , Trasplante de Corazón/patología , Animales , Apoptosis , Muerte Celular , Femenino , Rechazo de Injerto/epidemiología , Inmunización/métodos , Etiquetado Corte-Fin in Situ , Masculino , Embarazo , Ratas , Ratas Endogámicas Lew , Ratas Endogámicas WF , Trasplante de Piel/inmunología , Trasplante Homólogo/inmunología , Trasplante Homólogo/patología
5.
Transplant Proc ; 41(6): 2625-7, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19715988

RESUMEN

Graft vasculopathy (GVP) is one of the major obstacles to long-term graft and patient survival after cardiac transplantation and a major reason for morbidity and mortality. Antigen-dependent and antigen-independent factors play causal roles in the development of GVP. The aim of this study was to evaluate antigen-dependent and -independent factors in the development of GVR in a clinically relevant fully allogeneic rat cardiac model under immunosuppression with cyclosporine (CyA). Lewis rats were challenged with Wistar-Furth cardiac allografts. Acute rejection occurred within 10 days after engraftment (n = 6). Daily SC administration of CyA (2.5 mg/kg body weight, n = 12) led to long-term graft survival (>100 days) but did not prevent GVP (Adams Score: 1.7 +/- 1.9, n = 4). Isografts did not develop GVP. In allografts, the dose modification of CyA to 5 mg or 1.25 mg/kg body weight as well as the prolongation of ischemia from 45 minutes to 4 hours did not increase the development of GVP. In isografts, the prolongation of ischemic time from 45 minutes to 4 hours significantly increased the development of GVP (Adams score, 0.3 +/- 0.8 [n = 7] vs 1.2 +/- 1.9 [n = 6]; P < .05). In this fully allogeneic cardiac allograft model with clinically relevant immunosuppressive therapy, GVP was induced independent of the applied CyA dose. In addition, the prolongation of ischemic time did not increase the development of GVP. Isografts only developed significant GVP with long ischemia times. Therefore, an initial injury, either prolonged ischemia time or an allogeneic immune response, predispressed to the development of GVP.


Asunto(s)
Ciclosporina/uso terapéutico , Rechazo de Injerto/inmunología , Rechazo de Injerto/prevención & control , Supervivencia de Injerto/inmunología , Trasplante de Corazón/inmunología , Trasplante de Corazón/patología , Enfermedades Vasculares/patología , Animales , Rechazo de Injerto/patología , Supervivencia de Injerto/efectos de los fármacos , Inmunosupresores/uso terapéutico , Modelos Animales , Isquemia Miocárdica/fisiopatología , Complicaciones Posoperatorias/patología , Ratas , Ratas Endogámicas Lew , Ratas Endogámicas WF , Trasplante Homólogo/inmunología , Trasplante Homólogo/patología , Enfermedades Vasculares/etiología
6.
Thorac Cardiovasc Surg ; 57(5): 276-80, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19629889

RESUMEN

BACKGROUND: Atrial fibrillation (AF) is a common complication after coronary artery bypass grafting operation (CABG). Experimental data have shown antiarrhythmic effects of n-3 polyunsaturated fatty acids (PUFA) on myocardial cells. Orally administered PUFA could significantly reduce the rate of postoperative AF. We assessed the efficacy of PUFA for the prevention of AF after CABG. PUFA were given intravenously to prevent variation in bioavailability. METHODS AND RESULTS: 52 patients were randomized to the interventional group, 50 served as controls. In the control group free fatty acids (100 mg soya oil/kg body weight/day) were infused via perfusion pump, starting on admission to hospital and ending at discharge from intensive care. In the interventional group PUFA were given at a dosage of 100 mg fish oil/kg body weight/day. Primary end point was the postoperative development of AF, documented by surface ECG. Secondary end point was the length of stay in the ICU. The demographic, clinical and surgical characteristics of the patients in the two groups were similar. Postoperative AF occurred in 15 patients (30.6 %) in the control and in 9 (17.3 %) in the PUFA group ( P < 0.05). After CABG, the PUFA patients had to be treated in the ICU for a shorter time than the control patients. No adverse effects were observed. CONCLUSIONS: Perioperative intravenous infusion of PUFA reduces the incidence of AF after CABG and leads to a shorter stay in the ICU and in hospital. Our data suggest that perioperative intravenous infusion of PUFA should be recommended for patients undergoing CABG.


Asunto(s)
Antiarrítmicos/administración & dosificación , Fibrilación Atrial/prevención & control , Puente de Arteria Coronaria/efectos adversos , Ácidos Grasos Omega-3/administración & dosificación , Aceites de Pescado/administración & dosificación , Aceite de Soja/administración & dosificación , Anciano , Fibrilación Atrial/etiología , Fibrilación Atrial/fisiopatología , Cuidados Críticos , Método Doble Ciego , Electrocardiografía , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Infusiones Intravenosas , Tiempo de Internación , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Factores de Tiempo , Resultado del Tratamiento
7.
Thorac Cardiovasc Surg ; 57(2): 79-84, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19241308

RESUMEN

BACKGROUND: The effect of transmyocardial laser revascularization (TMLR) on microperfusion and oxygen supply was studied in an acute ischemia model, using 35 pigs, with 13 serving as controls. METHODS: Measurement of tissue oxygen tension was compared with the semiquantitative measurement of microperfusion using contrast echocardiography and infrared laser Doppler. All methods were used before and after coronary occlusion and after TMLR. Effects were measured in the ischemic area and in two ischemia independent areas. RESULTS: At baseline, oxygen partial pressure was 54.2 +/- 15.7 mmHg and decreased to 2.8 +/- 1.4 mmHg ( P < 0.05) after occlusion. After TMLR, oxygen tension increased to 27.3 +/- 8.5 mmHg ( P < 0.05) in the ischemic area, indicating a significant effect of TMLR on microperfusion and oxygen tension. Changes in regional oxygen tension corresponded to Levovist density changes in contrast echocardiography and changes in microperfusion measured by infrared laser Doppler. CONCLUSIONS: Our data indicate that measurement of tissue oxygen tension is a suitable experimental tool to assess the effect of TMLR on myocardial perfusion, which cannot be discriminated using clinical imaging methods.


Asunto(s)
Circulación Coronaria , Electroquímica , Terapia por Láser , Láseres de Excímeros , Isquemia Miocárdica/cirugía , Revascularización Miocárdica/métodos , Miocardio/metabolismo , Oxígeno/metabolismo , Enfermedad Aguda , Animales , Medios de Contraste , Modelos Animales de Enfermedad , Ecocardiografía/métodos , Electroquímica/instrumentación , Electrodos de Iones Selectos , Flujometría por Láser-Doppler , Masculino , Microcirculación , Isquemia Miocárdica/diagnóstico por imagen , Isquemia Miocárdica/metabolismo , Isquemia Miocárdica/fisiopatología , Oxígeno/sangre , Presión Parcial , Polisacáridos , Reproducibilidad de los Resultados , Porcinos
8.
Amino Acids ; 36(1): 1-11, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18283414

RESUMEN

Procedures for the analysis of free alpha-keto acids in human fluids (i.e. plasma, cerebrospinal fluid, urine, etc.) as well as for studying the dynamic free alpha-keto acid pools in differentiated tissues and organ cells have been the subject of growing clinical interest in the study of metabolic regulatory and pathophysiological phenomena. Due to the high instability and polarity of the alpha-keto acids being examined, the development of a quantitative and reproducible analysis of metabolically relevant intracellular alpha-keto acids still presents a substantial methodological challenge. The aim of small sample size, rapid, non-damaging and "metabolism-neutral" cell isolation, careful sample preparation and stability, as well as reproducible analytics technology is not often achieved. Only few of the methods described can satisfy the rigorous demands for an ultra-sensitive, comprehensive and rapid intracellular alpha-keto acid analysis.


Asunto(s)
Fraccionamiento Celular/métodos , Cromatografía Líquida de Alta Presión/métodos , Cetoácidos/análisis , Espectrometría de Fluorescencia/métodos , Animales , Cromatografía de Gases , Humanos , Cetoácidos/química , Cetoácidos/metabolismo
9.
Transplant Proc ; 40(4): 974-7, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18555093

RESUMEN

Acute cardiac allograft rejection remains a major cause of morbidity and mortality after heart transplantation and predisposes for the development of graft vasculopathy. The aim of this study was to investigate the immunomodulatory effect of preconditioning of the donor and recipient with medical ozone (O(3)/O(2)) on acute allograft rejection. Minimizing the initial ischemia-reperfusion injury may result in a reduction of graft vasculopathy and ameliorate long-term outcomes after cardiac transplantation. Lewis rats were challenged with Wistar-Furth cardiac allograft. In donor and recipient animals a medical ozone (O(3)/O(2))-pneumoperitoneum was induced by single (1x) or repetitive (5x) insufflation (concentration: 50 microg/mL, 80 mL/kg body weight) of medical ozone intraperitoneally. Without immunomodulatory therapy (n = 11) cardiac allograft survival was 5.9 +/- 0.9 days. Preconditioning with medical ozone alone (single bolus as well as repetitive administration, n = 7) of the donor and recipient animals prolonged cardiac allograft survival significantly to 7.6 +/- 1.4 days (P < .05), without any adjunctive immunosuppressive therapy. In this pilot study, the intraperitoneal administration of ozone in donor and recipient animals protected from ischemia-reperfusion injury, reduced the immunogenicity of the graft, and prolonged cardiac allograft survival. Further studies are warranted to elucidate the underlying mechanisms and--more important--to investigate the effect on the development of graft vasculopathy, the major obstacle to long-term graft and patient survivals.


Asunto(s)
Rechazo de Injerto/prevención & control , Trasplante de Corazón/fisiología , Inmunosupresores/uso terapéutico , Ozono/uso terapéutico , Trasplante Homólogo/fisiología , Animales , Masculino , Modelos Animales , Ratas , Ratas Endogámicas WF , Acondicionamiento Pretrasplante/métodos
10.
Amino Acids ; 34(2): 257-70, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17334904

RESUMEN

We examined the effects of beta-alanine (taurine analogue and taurine transport antagonist), taurine (regarding its role in neutrophil (PMN) immunonutrition) and taurine combined either with L-NAME (inhibitor of *NO-synthase), SNAP (*NO donor), DON (glutamine-analogue and inhibitor of glutamine-requiring enzymes), DFMO (inhibitor of ornithine-decarboxylase) and beta-alanine on neutrophil amino- and alpha-keto acid profiles or important PMN immune functions in order to establish whether taurine transport-, nitric oxide-, glutamine- or ornithine-dependent mechanisms are involved in any of the taurine-induced effects. According to the present findings, the taurine-mediated effect appears to be based primarily on a modulation of important transmembraneous transport mechanisms and only secondarily on directly or indirectly induced modifications in intragranulocytic amino- and alpha-keto acid homoeostasis or metabolism. Although a direct relation to the parallel observed immunological modifications can only be presumed, these results show very clearly that compositional modifications in the free intragranulocytic amino- and alpha keto-acid pools coinciding with changes in intragranulocytic taurine levels are relevant metabolic determinants that can significantly influence the magnitude and quality of the granulocytic immune response.


Asunto(s)
Aminoácidos/metabolismo , Homeostasis/efectos de los fármacos , Cetoácidos/metabolismo , Neutrófilos/fisiología , Taurina/fisiología , beta-Alanina/farmacología , Adulto , Diazooxonorleucina/farmacología , Eflornitina/farmacología , Humanos , Peróxido de Hidrógeno/metabolismo , Masculino , NG-Nitroarginina Metil Éster/farmacología , Neutrófilos/inmunología , Peroxidasa/metabolismo , S-Nitroso-N-Acetilpenicilamina/farmacología , Superóxidos/metabolismo
11.
Thorac Cardiovasc Surg ; 53(6): 346-51, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16311971

RESUMEN

In an acute porcine myocardial ischemia model we examined the effect of transmyocardial laser-revascularization (TMLR) on the regional micro perfusion and oxygen supply. In clinical practice, contrast echocardiography is a reliable tool for the measurement of changes in regional blood flow in the ischemic myocardium. We compared contrast echocardiography with the laser Doppler measurement of micro perfusion and with the quantification of regional tissue oxygen tension using a Clark electrode. 22 pigs were randomised in the interventional group and 12 in the control group. Measurements with all three methods were performed before and after occlusion of the first diagonal branch of the left anterior descending coronary artery and, in the interventional group, after TMLR. We investigated not only the effects in the dependent ischemic myocardium, but also in two other myocardial areas, not involved in the coronary occlusion. There was a significant effect of TMLR on regional micro perfusion and local oxygen tension in the dependent ischemic myocardial area. Contrast echocardiography is a successful experimental tool to measure changes in regional myocardial perfusion which cannot be perceived using clinical imaging methods.


Asunto(s)
Ecocardiografía/métodos , Terapia por Láser/métodos , Isquemia Miocárdica/cirugía , Revascularización Miocárdica/métodos , Animales , Ecocardiografía Doppler , Masculino , Dosis Máxima Tolerada , Isquemia Miocárdica/diagnóstico por imagen , Isquemia Miocárdica/fisiopatología , Distribución Aleatoria , Flujo Sanguíneo Regional , Porcinos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...